Orchestra BioMed develops medical technologies for cardiovascular care. It provides device development and partnership services, and it targets healthcare companies, physicians, and patients with heart and blood pressure conditions.
Orchestra BioMed products and services overview:
Revenue: ~$4 million
Employees: 70
Headquarters: New Hope, United States (USA)
Orchestra BioMed is one of the...
Orchestra BioMed is a company listed under the stock ticker OBIO (US).
View the org chart displaying its 38 main executives
Create your alert
to follow the executive moves at Orchestra BioMed.
Orchestra BioMed has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.